Perspective Therapeutics (CATX) Expected to Announce Quarterly Earnings on Wednesday
Perspective Therapeutics (NYSE:CATX – Get Free Report) will likely be posting its quarterly earnings results after the market ...
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $53.14 Average PT from Brokerages
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have received a consensus recommendation of “Buy” from the ...
Mineralys Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...
Kalaris Announces Closing of Merger with AlloVir
Kalaris is focused on developing TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased ...
PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...